Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
Pediatric Blood & Cancer|November 20, 2013
Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemiaAlix E Seif, Brian T Fisher, Yimei Li, et al.
Pediatric Blood & Cancer|November 12, 2022
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapyJohn C Molina, Yimei Li, William R Otto, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2019
Partially CD3<sup>+</sup>-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic MalignancyAlix E Seif, Yimei Li, Dimitri S Monos, et al.
Journal of the National Cancer Institute|January 31, 2026
Neurocognitive impairment and financial hardship in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor StudyDaniel J Zheng, Shalini Bhatia, Sedigheh Mirzaei, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 25, 2013
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United StatesShannon L Maude, Julie C Fitzgerald, Brian T Fisher, et al.
Blood|May 5, 2021
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology GroupKatherine Tarlock, Adam J Lamble, Yi-Cheng Wang, et al.
Cancers|April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 TrialAnneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood CancerEric J Chow, Sanjeev Aggarwal, David R Doody, et al.
Genome Medicine|May 29, 2019
Clinical utility of custom-designed NGS panel testing in pediatric tumorsLea F Surrey, Suzanne P MacFarland, Fengqi Chang, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
Pediatric Blood & Cancer|November 20, 2013
Patient and hospital factors associated with induction mortality in acute lymphoblastic leukemiaAlix E Seif, Brian T Fisher, Yimei Li, et al.
Pediatric Blood & Cancer|November 12, 2022
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapyJohn C Molina, Yimei Li, William R Otto, et al.
Cancer|October 13, 2021
Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology GroupEric J Chow, Richard Aplenc, Lynda M Vrooman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2019
Partially CD3<sup>+</sup>-Depleted Unrelated and Haploidentical Donor Peripheral Stem Cell Transplantation Has Favorable Graft-versus-Host Disease and Survival Rates in Pediatric Hematologic MalignancyAlix E Seif, Yimei Li, Dimitri S Monos, et al.
Journal of the National Cancer Institute|January 31, 2026
Neurocognitive impairment and financial hardship in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor StudyDaniel J Zheng, Shalini Bhatia, Sedigheh Mirzaei, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 25, 2013
Outcome of pediatric acute myeloid leukemia patients receiving intensive care in the United StatesShannon L Maude, Julie C Fitzgerald, Brian T Fisher, et al.
Blood|May 5, 2021
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology GroupKatherine Tarlock, Adam J Lamble, Yi-Cheng Wang, et al.
Cancers|April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 TrialAnneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood CancerEric J Chow, Sanjeev Aggarwal, David R Doody, et al.
Genome Medicine|May 29, 2019
Clinical utility of custom-designed NGS panel testing in pediatric tumorsLea F Surrey, Suzanne P MacFarland, Fengqi Chang, et al.
Pageof 26